Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Pediatric ulcerative colitis


Other Names for this Disease

  • Ulcerative colitis, pediatric
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Clinical Trials & Research for this Disease

  • ClinicalTrials.gov lists trials that are studying or have studied Pediatric ulcerative colitis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.

Medical Products

The medication(s) listed in the table(s) below have been approved by the Food and Drug Administration (FDA) for treatment of this condition. The FDA Office of Orphan Products Development designates "orphan products" for those that treat rare diseases affecting fewer than 200,000 Americans. The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products. To search for all FDA approved drugs, visit Drugs@FDA. You can find orphan products used to treat other conditions by searching the Orphan Drug Product Designation database.


Generic Name Balsalazide disodium
Trade Name
(Manufacturer Name)
Colazal®
(Salix Pharmaceuticals, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. Safety and Effectiveness of Colazal beyond 8 weeks in children (ages 5-17) and 12 weeks in adults have not been established.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Infliximab
Trade Name
(Manufacturer Name)
Remicade
(Janssen Biotech)
Indication
The FDA has approved this product to be used in this manner.
For reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients 6 years of age and older with moderately to severely active ulcerative colitis who have had an inadequate response to conventional therapy.
More Information about this product Drug Information Portal
Medline Plus Health Information

Other Names for this Disease
  • Ulcerative colitis, pediatric
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.